Current:Home > FinancePrincess Kate makes first public appearance at church service after finishing chemo -Excel Wealth Summit
Princess Kate makes first public appearance at church service after finishing chemo
Indexbit Exchange View
Date:2025-04-09 11:53:28
Princess Kate has made her first public appearance since completing chemotherapy earlier this month.
Kate, 42, and Prince William attended church Sunday with King Charles III and Queen Camilla at the royal family's place of worship in Scotland near their Balmoral castle estate, according to The Associated Press.
The Princess of Wales revealed in a video message on Sept. 9 that she feels "relief" after completing her chemotherapy treatment. She said her focus is now on "doing what I can to stay cancer-free," and despite finishing chemo, her "path to healing and full recovery" remains "long."
"I must continue to take each day as it comes," she said. "I am, however, looking forward to being back at work and undertaking a few more public engagements in the coming months when I can. Despite all that's gone before, I enter this new phase of recovery with a renewed sense of hope and appreciation of life."
Kate has attended a few public events during her cancer treatment. In June, she made her public return at the Trooping the Colour, the ceremonial celebration of King Charles' birthday. Charles is also battling an unspecified form of cancer.
Need a break? Play the USA TODAY Daily Crossword Puzzle.
Princess Kateseen in rare outing for church service in Scotland
The following month, she made an appearance with her daughter, Princess Charlotte, at Wimbledon and received a standing ovation. In August, Kate was seen attending service at Crathie Kirk parish church in Scotland with William, 42, Charles, 75, and Camilla, 77, alongside Prince Edward and his wife Sophie, the Duchess of Edinburgh, and their son, James, Earl of Wessex, according to photos shared by the Daily Mail.
The church is best known as the place of worship for the family when staying at Balmoral Castle in Aberdeenshire, Scotland.
Contributing: Brendan Morrow
veryGood! (8617)
Related
- Biden administration makes final diplomatic push for stability across a turbulent Mideast
- Warning for Seafood Lovers: Climate Change Could Crash These Important Fisheries
- Feds move to block $69 billion Microsoft-Activision merger
- Mall operator abandons San Francisco amid retail exodus from city
- North Carolina justices rule for restaurants in COVID
- Seattle's schools are suing tech giants for harming young people's mental health
- Natural Climate Solutions Could Cancel Out a Fifth of U.S. Emissions, Study Finds
- Michigan 2-year-old dies in accidental shooting at home
- North Carolina trustees approve Bill Belichick’s deal ahead of introductory news conference
- Dakota Access Prone to Spills, Should Be Rerouted, Says Pipeline Safety Expert
Ranking
- Sonya Massey's father decries possible release of former deputy charged with her death
- Michigan County Embraces Giant Wind Farms, Bucking a Trend
- Proof Matty Healy Is Already Bonding With Taylor Swift’s Family Amid Budding Romance
- A newborn was surrendered to Florida's only safe haven baby box. Here's how they work
- Grammy nominee Teddy Swims on love, growth and embracing change
- Why Gratitude Is a Key Ingredient in Rachael Ray's Recipe for Rebuilding Her Homes
- Mall operator abandons San Francisco amid retail exodus from city
- Farmers, Don’t Count on Technology to Protect Agriculture from Climate Change
Recommendation
Paris Hilton, Nicole Richie return for an 'Encore,' reminisce about 'The Simple Life'
Inside Blake Lively's Family World With Ryan Reynolds, 4 Kids and Countless Wisecracks
Kendall Jenner and Bad Bunny's Latest Date Night Proves They're In Sync
Chef Sylvain Delpique Shares What’s in His Kitchen, Including a $5 Must-Have
All That You Wanted to Know About She’s All That
24-Hour Flash Deal: Save 55% On the Cult Favorite Josie Maran Whipped Argan Body Butter
Get Budge-Proof, Natural-Looking Eyebrows With This 44% Off Deal From It Cosmetics
FDA approves Alzheimer's drug that appears to modestly slow disease